Atlas Trials

Topical Gentamicin Nonsense Suppression Therapy of EB

Clinical trial NCT04644627 · COMPLETED

Trial details

NCT number
NCT04644627
Sponsor
Oslo University Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Epidermolysis Bullosa
Start date
2020-12-01
Primary completion
2022-01-11
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.